 Rachel Frank
Concepts (852)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroscopy | 58 | 2025 | 267 | 9.610 |
Why?
| | Shoulder Joint | 50 | 2024 | 198 | 9.120 |
Why?
| | Joint Instability | 36 | 2024 | 182 | 8.590 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 21 | 2026 | 192 | 5.730 |
Why?
| | Cartilage, Articular | 24 | 2026 | 343 | 5.090 |
Why?
| | Anterior Cruciate Ligament Injuries | 21 | 2026 | 216 | 4.790 |
Why?
| | Knee Joint | 31 | 2026 | 426 | 4.620 |
Why?
| | Sports Medicine | 12 | 2026 | 117 | 4.480 |
Why?
| | Knee Injuries | 18 | 2022 | 122 | 4.450 |
Why?
| | Tibial Meniscus Injuries | 12 | 2025 | 62 | 4.390 |
Why?
| | Biological Products | 12 | 2024 | 252 | 4.230 |
Why?
| | Shoulder Dislocation | 17 | 2026 | 61 | 4.220 |
Why?
| | Orthopedic Procedures | 19 | 2021 | 243 | 4.130 |
Why?
| | Tibia | 14 | 2025 | 176 | 4.120 |
Why?
| | Platelet-Rich Plasma | 14 | 2026 | 41 | 4.030 |
Why?
| | Menisci, Tibial | 17 | 2025 | 78 | 3.920 |
Why?
| | Athletic Injuries | 23 | 2026 | 569 | 3.850 |
Why?
| | Orthopedics | 13 | 2026 | 169 | 3.830 |
Why?
| | Rotator Cuff Injuries | 13 | 2026 | 79 | 3.530 |
Why?
| | Bone Transplantation | 14 | 2025 | 86 | 3.410 |
Why?
| | Osteotomy | 12 | 2025 | 127 | 3.250 |
Why?
| | Osteoarthritis, Knee | 18 | 2026 | 279 | 3.060 |
Why?
| | Femoracetabular Impingement | 8 | 2018 | 35 | 2.820 |
Why?
| | Simulation Training | 6 | 2024 | 134 | 2.770 |
Why?
| | Hip Joint | 8 | 2018 | 172 | 2.290 |
Why?
| | Tenodesis | 8 | 2020 | 20 | 2.260 |
Why?
| | Cartilage Diseases | 5 | 2019 | 45 | 2.230 |
Why?
| | Arthroplasty, Replacement, Knee | 9 | 2025 | 370 | 2.180 |
Why?
| | Arthroplasty | 10 | 2020 | 59 | 2.160 |
Why?
| | Reoperation | 29 | 2023 | 630 | 2.120 |
Why?
| | Meniscus | 4 | 2023 | 23 | 2.040 |
Why?
| | Humans | 312 | 2026 | 144759 | 1.980 |
Why?
| | Allografts | 19 | 2025 | 150 | 1.960 |
Why?
| | Rotator Cuff | 9 | 2026 | 59 | 1.930 |
Why?
| | Shoulder Injuries | 9 | 2024 | 66 | 1.890 |
Why?
| | Tendons | 11 | 2026 | 129 | 1.730 |
Why?
| | Shoulder | 22 | 2023 | 105 | 1.710 |
Why?
| | Arthroplasty, Replacement, Shoulder | 9 | 2020 | 40 | 1.650 |
Why?
| | Postoperative Complications | 25 | 2026 | 2919 | 1.640 |
Why?
| | Return to Sport | 10 | 2025 | 117 | 1.640 |
Why?
| | Cartilage | 10 | 2025 | 198 | 1.620 |
Why?
| | Transplantation, Homologous | 19 | 2025 | 415 | 1.610 |
Why?
| | Computer Simulation | 6 | 2021 | 1025 | 1.610 |
Why?
| | Sports | 7 | 2023 | 211 | 1.580 |
Why?
| | Patient Reported Outcome Measures | 11 | 2026 | 488 | 1.510 |
Why?
| | Suture Anchors | 7 | 2021 | 35 | 1.470 |
Why?
| | Musculoskeletal Diseases | 5 | 2024 | 88 | 1.450 |
Why?
| | Clinical Competence | 8 | 2024 | 1244 | 1.430 |
Why?
| | Athletes | 7 | 2023 | 419 | 1.430 |
Why?
| | Scapula | 11 | 2023 | 48 | 1.430 |
Why?
| | Internship and Residency | 9 | 2026 | 1257 | 1.430 |
Why?
| | Acromioclavicular Joint | 3 | 2023 | 12 | 1.420 |
Why?
| | Tendon Injuries | 5 | 2019 | 73 | 1.330 |
Why?
| | Adult | 132 | 2026 | 40449 | 1.280 |
Why?
| | Young Adult | 53 | 2026 | 14105 | 1.190 |
Why?
| | Treatment Outcome | 51 | 2026 | 11679 | 1.180 |
Why?
| | Femur | 9 | 2025 | 250 | 1.170 |
Why?
| | Second-Look Surgery | 3 | 2025 | 8 | 1.170 |
Why?
| | Male | 166 | 2026 | 72315 | 1.130 |
Why?
| | Humeral Head | 7 | 2023 | 20 | 1.090 |
Why?
| | Female | 161 | 2026 | 78271 | 1.090 |
Why?
| | Evidence-Based Medicine | 7 | 2020 | 732 | 1.080 |
Why?
| | Bankart Lesions | 4 | 2023 | 11 | 1.060 |
Why?
| | Arthroplasty, Subchondral | 4 | 2018 | 7 | 1.050 |
Why?
| | Biomechanical Phenomena | 18 | 2026 | 842 | 1.030 |
Why?
| | Quadriceps Muscle | 3 | 2026 | 118 | 1.030 |
Why?
| | Anterior Cruciate Ligament | 9 | 2023 | 101 | 1.020 |
Why?
| | Middle Aged | 106 | 2026 | 35875 | 1.000 |
Why?
| | Bone Malalignment | 2 | 2025 | 12 | 0.980 |
Why?
| | Bone Screws | 5 | 2020 | 110 | 0.980 |
Why?
| | Female Athlete Triad Syndrome | 2 | 2017 | 3 | 0.970 |
Why?
| | Joint Dislocations | 2 | 2024 | 60 | 0.970 |
Why?
| | Ligaments, Articular | 5 | 2023 | 54 | 0.960 |
Why?
| | Hemiarthroplasty | 3 | 2020 | 10 | 0.930 |
Why?
| | Education, Medical, Graduate | 5 | 2019 | 557 | 0.930 |
Why?
| | Osteoarthritis | 7 | 2019 | 196 | 0.920 |
Why?
| | Range of Motion, Articular | 17 | 2023 | 421 | 0.920 |
Why?
| | Orthopedic Surgeons | 2 | 2023 | 30 | 0.880 |
Why?
| | Achilles Tendon | 2 | 2023 | 35 | 0.850 |
Why?
| | Follow-Up Studies | 37 | 2021 | 5408 | 0.830 |
Why?
| | Blood Loss, Surgical | 2 | 2014 | 112 | 0.800 |
Why?
| | Cadaver | 13 | 2020 | 304 | 0.790 |
Why?
| | Adolescent | 77 | 2025 | 22428 | 0.790 |
Why?
| | Social Media | 2 | 2024 | 171 | 0.740 |
Why?
| | Brain Concussion | 5 | 2025 | 640 | 0.730 |
Why?
| | Venous Thrombosis | 2 | 2022 | 194 | 0.720 |
Why?
| | Retrospective Studies | 57 | 2025 | 17066 | 0.710 |
Why?
| | Lacerations | 1 | 2022 | 40 | 0.700 |
Why?
| | Pain | 6 | 2018 | 779 | 0.700 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2014 | 182 | 0.700 |
Why?
| | Golf | 1 | 2020 | 9 | 0.650 |
Why?
| | Bone Resorption | 3 | 2018 | 80 | 0.650 |
Why?
| | Rupture | 8 | 2023 | 91 | 0.640 |
Why?
| | Hypertension | 12 | 2025 | 1263 | 0.630 |
Why?
| | Skiing | 1 | 2021 | 49 | 0.630 |
Why?
| | Radiography | 16 | 2019 | 844 | 0.630 |
Why?
| | Suture Techniques | 8 | 2019 | 131 | 0.610 |
Why?
| | Hamstring Muscles | 2 | 2018 | 22 | 0.610 |
Why?
| | Internet | 3 | 2022 | 699 | 0.590 |
Why?
| | Physical Examination | 9 | 2018 | 239 | 0.590 |
Why?
| | Humerus | 7 | 2020 | 39 | 0.580 |
Why?
| | Aged | 72 | 2025 | 25913 | 0.580 |
Why?
| | Stress, Mechanical | 4 | 2026 | 494 | 0.560 |
Why?
| | Kidney Transplantation | 6 | 2024 | 704 | 0.550 |
Why?
| | Swimming | 1 | 2018 | 50 | 0.550 |
Why?
| | Prosthesis Failure | 5 | 2015 | 127 | 0.540 |
Why?
| | Tenotomy | 1 | 2018 | 22 | 0.540 |
Why?
| | Virtual Reality | 1 | 2019 | 77 | 0.540 |
Why?
| | Yoga | 1 | 2018 | 31 | 0.530 |
Why?
| | Adipose Tissue | 6 | 2025 | 652 | 0.530 |
Why?
| | Glenoid Cavity | 2 | 2015 | 9 | 0.530 |
Why?
| | Carcinoma, Renal Cell | 4 | 2019 | 234 | 0.530 |
Why?
| | Meniscectomy | 3 | 2025 | 18 | 0.530 |
Why?
| | Leg Injuries | 1 | 2017 | 23 | 0.530 |
Why?
| | Treatment Failure | 6 | 2020 | 365 | 0.530 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 324 | 0.520 |
Why?
| | Facial Recognition | 1 | 2018 | 35 | 0.520 |
Why?
| | Bone Density | 2 | 2021 | 482 | 0.520 |
Why?
| | Facial Expression | 1 | 2018 | 74 | 0.520 |
Why?
| | Fractures, Stress | 1 | 2017 | 31 | 0.520 |
Why?
| | Imaging, Three-Dimensional | 4 | 2018 | 583 | 0.510 |
Why?
| | Olecranon Process | 1 | 2017 | 7 | 0.510 |
Why?
| | Bundle of His | 1 | 2017 | 19 | 0.510 |
Why?
| | Prosthesis-Related Infections | 2 | 2015 | 99 | 0.500 |
Why?
| | Cumulative Trauma Disorders | 1 | 2017 | 30 | 0.500 |
Why?
| | Fractures, Ununited | 1 | 2017 | 27 | 0.500 |
Why?
| | Transplantation, Autologous | 7 | 2026 | 290 | 0.500 |
Why?
| | Ulna Fractures | 1 | 2017 | 15 | 0.500 |
Why?
| | Open Fracture Reduction | 1 | 2017 | 30 | 0.500 |
Why?
| | Bicycling | 1 | 2017 | 120 | 0.500 |
Why?
| | Social Perception | 1 | 2018 | 107 | 0.500 |
Why?
| | Injections, Intra-Articular | 9 | 2025 | 58 | 0.500 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2025 | 59 | 0.500 |
Why?
| | Hip | 3 | 2014 | 57 | 0.490 |
Why?
| | Muscle, Skeletal | 8 | 2020 | 1795 | 0.490 |
Why?
| | Atrioventricular Block | 1 | 2017 | 45 | 0.490 |
Why?
| | Chondrocytes | 2 | 2018 | 232 | 0.480 |
Why?
| | Databases, Factual | 10 | 2019 | 1486 | 0.480 |
Why?
| | Osteosarcoma | 2 | 2015 | 76 | 0.470 |
Why?
| | Sex Factors | 8 | 2026 | 2112 | 0.460 |
Why?
| | Ozone | 4 | 2001 | 132 | 0.460 |
Why?
| | Kidney Neoplasms | 4 | 2019 | 412 | 0.460 |
Why?
| | Incidence | 13 | 2025 | 2879 | 0.460 |
Why?
| | Magnetic Resonance Imaging | 8 | 2026 | 3863 | 0.460 |
Why?
| | Soft Tissue Injuries | 1 | 2016 | 34 | 0.460 |
Why?
| | Patellar Ligament | 2 | 2014 | 26 | 0.460 |
Why?
| | Risk Factors | 25 | 2025 | 10779 | 0.450 |
Why?
| | Stereotyping | 1 | 2015 | 47 | 0.450 |
Why?
| | Comprehension | 2 | 2014 | 180 | 0.440 |
Why?
| | Prejudice | 1 | 2015 | 60 | 0.440 |
Why?
| | Electrocardiography | 5 | 2017 | 662 | 0.440 |
Why?
| | Bone-Patellar Tendon-Bone Grafts | 1 | 2014 | 3 | 0.440 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 5 | 2023 | 68 | 0.430 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2017 | 152 | 0.430 |
Why?
| | Ilium | 1 | 2014 | 30 | 0.430 |
Why?
| | Cohort Studies | 14 | 2023 | 5960 | 0.430 |
Why?
| | Child | 52 | 2025 | 22633 | 0.430 |
Why?
| | Arthroplasty, Replacement | 5 | 2016 | 47 | 0.420 |
Why?
| | Fracture Fixation, Internal | 1 | 2017 | 207 | 0.420 |
Why?
| | Hip Injuries | 1 | 2014 | 14 | 0.420 |
Why?
| | Blood Pressure | 9 | 2025 | 1769 | 0.420 |
Why?
| | Patient Education as Topic | 4 | 2024 | 780 | 0.420 |
Why?
| | Patellofemoral Joint | 2 | 2023 | 8 | 0.410 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2014 | 780 | 0.410 |
Why?
| | Hip Prosthesis | 1 | 2014 | 42 | 0.400 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 28 | 0.400 |
Why?
| | Materials Testing | 2 | 2017 | 354 | 0.400 |
Why?
| | Patient Satisfaction | 3 | 2018 | 704 | 0.390 |
Why?
| | Models, Educational | 1 | 2013 | 89 | 0.390 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 71 | 0.390 |
Why?
| | Graft Survival | 6 | 2019 | 526 | 0.390 |
Why?
| | Body Mass Index | 6 | 2025 | 2438 | 0.390 |
Why?
| | Bone and Bones | 1 | 2016 | 314 | 0.390 |
Why?
| | Delphi Technique | 9 | 2025 | 329 | 0.390 |
Why?
| | Emotions | 2 | 2018 | 578 | 0.390 |
Why?
| | Models, Anatomic | 1 | 2013 | 84 | 0.380 |
Why?
| | Time-to-Treatment | 1 | 2015 | 243 | 0.380 |
Why?
| | Liposarcoma | 1 | 2013 | 31 | 0.380 |
Why?
| | Recurrence | 15 | 2023 | 1135 | 0.380 |
Why?
| | Postoperative Period | 8 | 2019 | 354 | 0.370 |
Why?
| | Education, Medical, Continuing | 1 | 2013 | 132 | 0.370 |
Why?
| | Pain Measurement | 9 | 2025 | 552 | 0.370 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 58 | 0.370 |
Why?
| | Femur Head | 1 | 2012 | 39 | 0.370 |
Why?
| | Femur Neck | 1 | 2012 | 62 | 0.370 |
Why?
| | Autism Spectrum Disorder | 1 | 2018 | 412 | 0.370 |
Why?
| | Acetabulum | 2 | 2014 | 111 | 0.360 |
Why?
| | Pain Management | 2 | 2014 | 405 | 0.360 |
Why?
| | Nephrectomy | 2 | 2013 | 158 | 0.360 |
Why?
| | Surveys and Questionnaires | 10 | 2026 | 6048 | 0.360 |
Why?
| | Universities | 1 | 2014 | 452 | 0.360 |
Why?
| | Musculoskeletal System | 2 | 2022 | 49 | 0.350 |
Why?
| | Rotation | 3 | 2018 | 121 | 0.340 |
Why?
| | Hyaluronic Acid | 7 | 2025 | 208 | 0.340 |
Why?
| | Age Factors | 11 | 2019 | 3333 | 0.330 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2730 | 0.330 |
Why?
| | Nephrotic Syndrome | 4 | 2022 | 44 | 0.330 |
Why?
| | Physical Therapy Modalities | 4 | 2026 | 332 | 0.320 |
Why?
| | Activities of Daily Living | 4 | 2018 | 441 | 0.320 |
Why?
| | Football | 3 | 2017 | 89 | 0.310 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2026 | 1720 | 0.310 |
Why?
| | United States | 22 | 2025 | 15966 | 0.310 |
Why?
| | Stem Cell Transplantation | 3 | 2020 | 191 | 0.310 |
Why?
| | Practice Patterns, Physicians' | 4 | 2026 | 1356 | 0.300 |
Why?
| | Health Care Surveys | 3 | 2017 | 539 | 0.300 |
Why?
| | Random Allocation | 4 | 2019 | 363 | 0.300 |
Why?
| | Joint Prosthesis | 3 | 2015 | 22 | 0.300 |
Why?
| | Aged, 80 and over | 22 | 2021 | 8265 | 0.300 |
Why?
| | Reproducibility of Results | 9 | 2024 | 3409 | 0.300 |
Why?
| | Pilot Projects | 7 | 2021 | 1886 | 0.280 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2023 | 124 | 0.280 |
Why?
| | Patient Readmission | 3 | 2018 | 758 | 0.260 |
Why?
| | Mass Screening | 2 | 2014 | 1347 | 0.250 |
Why?
| | Joint Diseases | 3 | 2019 | 62 | 0.250 |
Why?
| | Nephrology | 2 | 2024 | 60 | 0.250 |
Why?
| | Time Factors | 20 | 2026 | 7173 | 0.250 |
Why?
| | Glomerulosclerosis, Focal Segmental | 4 | 2016 | 43 | 0.250 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 80 | 0.240 |
Why?
| | Attitude of Health Personnel | 2 | 2026 | 1185 | 0.240 |
Why?
| | Arthralgia | 2 | 2025 | 61 | 0.240 |
Why?
| | Patient Positioning | 2 | 2019 | 70 | 0.240 |
Why?
| | Risk Assessment | 9 | 2025 | 3671 | 0.240 |
Why?
| | Platelet Count | 1 | 2026 | 96 | 0.240 |
Why?
| | Infant Mortality | 2 | 2004 | 123 | 0.230 |
Why?
| | Synovectomy | 1 | 2025 | 8 | 0.230 |
Why?
| | Matched-Pair Analysis | 2 | 2016 | 37 | 0.230 |
Why?
| | Synovitis | 1 | 2025 | 33 | 0.230 |
Why?
| | Video Recording | 2 | 2024 | 212 | 0.230 |
Why?
| | Operative Time | 1 | 2026 | 175 | 0.230 |
Why?
| | Recovery of Function | 8 | 2026 | 707 | 0.220 |
Why?
| | Head Injuries, Closed | 1 | 2025 | 49 | 0.220 |
Why?
| | Electrocoagulation | 4 | 2014 | 36 | 0.220 |
Why?
| | Soccer | 1 | 2025 | 38 | 0.220 |
Why?
| | Pulmonary Embolism | 3 | 2018 | 244 | 0.220 |
Why?
| | Wound Healing | 3 | 2013 | 351 | 0.220 |
Why?
| | Respiratory Mechanics | 2 | 1995 | 72 | 0.220 |
Why?
| | Complement Activation | 2 | 2025 | 411 | 0.220 |
Why?
| | Humeral Fractures | 2 | 2017 | 46 | 0.220 |
Why?
| | Tachycardia, Ventricular | 4 | 2000 | 181 | 0.210 |
Why?
| | Viscosupplements | 3 | 2020 | 11 | 0.210 |
Why?
| | Autografts | 3 | 2026 | 55 | 0.210 |
Why?
| | Complement Factor H | 1 | 2025 | 80 | 0.210 |
Why?
| | Reading | 3 | 2014 | 136 | 0.210 |
Why?
| | Catheter Ablation | 5 | 2000 | 353 | 0.210 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1053 | 0.210 |
Why?
| | Caffeine | 1 | 2024 | 74 | 0.210 |
Why?
| | Synovial Membrane | 1 | 2025 | 124 | 0.210 |
Why?
| | Patellar Dislocation | 1 | 2023 | 8 | 0.200 |
Why?
| | Consensus | 5 | 2025 | 488 | 0.200 |
Why?
| | Bone Marrow | 3 | 2023 | 304 | 0.200 |
Why?
| | Prehypertension | 1 | 2023 | 27 | 0.200 |
Why?
| | Curriculum | 2 | 2021 | 1059 | 0.200 |
Why?
| | Prognosis | 13 | 2020 | 4282 | 0.200 |
Why?
| | Prospective Studies | 10 | 2023 | 7990 | 0.200 |
Why?
| | Heart Ventricles | 5 | 2019 | 760 | 0.200 |
Why?
| | Cross-Sectional Studies | 10 | 2026 | 5868 | 0.190 |
Why?
| | Sutures | 3 | 2019 | 64 | 0.190 |
Why?
| | Muscle Strength | 1 | 2026 | 330 | 0.190 |
Why?
| | Urolithiasis | 2 | 2016 | 11 | 0.190 |
Why?
| | Ankle Injuries | 1 | 2023 | 65 | 0.190 |
Why?
| | Debridement | 4 | 2017 | 86 | 0.190 |
Why?
| | Case-Control Studies | 5 | 2026 | 3604 | 0.180 |
Why?
| | Postoperative Care | 4 | 2019 | 288 | 0.180 |
Why?
| | Research Design | 2 | 2018 | 1135 | 0.180 |
Why?
| | Intra-Articular Fractures | 2 | 2019 | 19 | 0.180 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.180 |
Why?
| | Osteoarthritis, Hip | 1 | 2021 | 45 | 0.170 |
Why?
| | Urinary Diversion | 2 | 1998 | 13 | 0.170 |
Why?
| | Preoperative Period | 2 | 2018 | 149 | 0.170 |
Why?
| | Knee Dislocation | 1 | 2021 | 6 | 0.170 |
Why?
| | Biology | 1 | 2022 | 91 | 0.170 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2168 | 0.170 |
Why?
| | Arm | 2 | 2019 | 109 | 0.170 |
Why?
| | Verbal Learning | 2 | 2007 | 73 | 0.170 |
Why?
| | Drug Chronotherapy | 1 | 2020 | 2 | 0.170 |
Why?
| | Ankle | 2 | 2019 | 63 | 0.170 |
Why?
| | Comorbidity | 5 | 2018 | 1658 | 0.170 |
Why?
| | Operating Rooms | 2 | 2024 | 146 | 0.160 |
Why?
| | Arthritis, Rheumatoid | 4 | 2025 | 1169 | 0.160 |
Why?
| | Socioeconomic Factors | 2 | 2004 | 1326 | 0.160 |
Why?
| | Antihypertensive Agents | 2 | 2020 | 510 | 0.160 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 1 | 2000 | 60 | 0.160 |
Why?
| | Marketing of Health Services | 1 | 2020 | 15 | 0.160 |
Why?
| | Echocardiography | 4 | 2020 | 652 | 0.160 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2020 | 8 | 0.160 |
Why?
| | Delayed Graft Function | 2 | 2018 | 46 | 0.150 |
Why?
| | Osteonecrosis | 1 | 2020 | 23 | 0.150 |
Why?
| | Absorptiometry, Photon | 1 | 2021 | 276 | 0.150 |
Why?
| | Multiple Trauma | 1 | 2021 | 116 | 0.150 |
Why?
| | Algorithms | 3 | 2023 | 1837 | 0.150 |
Why?
| | Kidney | 7 | 2016 | 1495 | 0.150 |
Why?
| | Spinal Neoplasms | 1 | 2019 | 37 | 0.150 |
Why?
| | Intraoperative Complications | 2 | 2012 | 155 | 0.150 |
Why?
| | Bone Substitutes | 1 | 2019 | 26 | 0.150 |
Why?
| | Kidney Diseases | 3 | 2024 | 427 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2023 | 365 | 0.140 |
Why?
| | Tensile Strength | 1 | 2019 | 96 | 0.140 |
Why?
| | Workers' Compensation | 1 | 2019 | 28 | 0.140 |
Why?
| | Graft Rejection | 3 | 2018 | 540 | 0.140 |
Why?
| | Pudendal Nerve | 1 | 2018 | 2 | 0.140 |
Why?
| | Surgeons | 1 | 2023 | 339 | 0.140 |
Why?
| | Shoulder Impingement Syndrome | 2 | 2018 | 7 | 0.140 |
Why?
| | Acromion | 2 | 2017 | 8 | 0.140 |
Why?
| | Odds Ratio | 2 | 2018 | 1075 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 34 | 0.140 |
Why?
| | Immunosuppressive Agents | 3 | 2008 | 846 | 0.140 |
Why?
| | Thinness | 1 | 2018 | 99 | 0.140 |
Why?
| | Mycophenolic Acid | 3 | 2008 | 120 | 0.140 |
Why?
| | Prosthesis Design | 3 | 2015 | 357 | 0.130 |
Why?
| | Osteochondritis Dissecans | 1 | 2018 | 14 | 0.130 |
Why?
| | Urinary Bladder Diseases | 1 | 1998 | 18 | 0.130 |
Why?
| | Radius | 1 | 2018 | 52 | 0.130 |
Why?
| | Arthrography | 1 | 2017 | 18 | 0.130 |
Why?
| | Spine | 1 | 2019 | 182 | 0.130 |
Why?
| | Bone Marrow Transplantation | 1 | 2019 | 294 | 0.130 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 301 | 0.130 |
Why?
| | Child, Preschool | 19 | 2025 | 11787 | 0.130 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 265 | 0.130 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 316 | 0.130 |
Why?
| | Hospital Charges | 1 | 2017 | 46 | 0.130 |
Why?
| | Obesity | 2 | 2018 | 3077 | 0.130 |
Why?
| | Multiple Sclerosis | 3 | 2008 | 484 | 0.130 |
Why?
| | Length of Stay | 3 | 2018 | 1337 | 0.130 |
Why?
| | Nephrons | 1 | 2016 | 23 | 0.130 |
Why?
| | Bronchi | 2 | 1996 | 267 | 0.130 |
Why?
| | Hypercalciuria | 1 | 2016 | 2 | 0.130 |
Why?
| | Anticoagulants | 1 | 2022 | 722 | 0.120 |
Why?
| | Orthopedic Fixation Devices | 1 | 2016 | 8 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2016 | 14 | 0.120 |
Why?
| | Patient Safety | 1 | 2020 | 347 | 0.120 |
Why?
| | Fever | 2 | 2017 | 311 | 0.120 |
Why?
| | Medical History Taking | 2 | 2014 | 117 | 0.120 |
Why?
| | Dementia | 1 | 2000 | 303 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2023 | 696 | 0.120 |
Why?
| | Elbow Joint | 1 | 2016 | 74 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2018 | 285 | 0.120 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1489 | 0.110 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2014 | 192 | 0.110 |
Why?
| | Glomerular Filtration Rate | 6 | 2020 | 760 | 0.110 |
Why?
| | Femoral Neck Fractures | 1 | 2015 | 21 | 0.110 |
Why?
| | Femoral Neoplasms | 1 | 2015 | 10 | 0.110 |
Why?
| | Tendinopathy | 1 | 2015 | 32 | 0.110 |
Why?
| | Lung Diseases | 2 | 2001 | 787 | 0.110 |
Why?
| | Kidney Failure, Chronic | 3 | 2018 | 598 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 338 | 0.110 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 13 | 0.110 |
Why?
| | Limb Salvage | 1 | 2015 | 70 | 0.110 |
Why?
| | Ontario | 3 | 2023 | 96 | 0.110 |
Why?
| | Hemodilution | 1 | 2014 | 11 | 0.110 |
Why?
| | Journal Impact Factor | 1 | 2014 | 29 | 0.110 |
Why?
| | Fracture Fixation | 1 | 2015 | 79 | 0.110 |
Why?
| | Immobilization | 2 | 2026 | 53 | 0.110 |
Why?
| | Menstrual Cycle | 1 | 1995 | 140 | 0.110 |
Why?
| | Tachycardia | 4 | 1989 | 57 | 0.110 |
Why?
| | Arthritis | 2 | 2016 | 96 | 0.110 |
Why?
| | Hemostasis, Surgical | 1 | 2014 | 27 | 0.110 |
Why?
| | Spinal Stenosis | 1 | 2014 | 31 | 0.100 |
Why?
| | Tourniquets | 1 | 2014 | 34 | 0.100 |
Why?
| | Running | 1 | 2016 | 228 | 0.100 |
Why?
| | Military Personnel | 2 | 2020 | 741 | 0.100 |
Why?
| | Intervertebral Disc Displacement | 1 | 2014 | 41 | 0.100 |
Why?
| | Professional Practice | 1 | 2014 | 57 | 0.100 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 338 | 0.100 |
Why?
| | Prostheses and Implants | 1 | 2015 | 141 | 0.100 |
Why?
| | Malnutrition | 1 | 2015 | 86 | 0.100 |
Why?
| | Prosthesis Implantation | 1 | 2015 | 153 | 0.100 |
Why?
| | Electromyography | 1 | 2016 | 415 | 0.100 |
Why?
| | Pressure | 1 | 2014 | 225 | 0.100 |
Why?
| | Hemostatics | 1 | 2014 | 61 | 0.100 |
Why?
| | Referral and Consultation | 3 | 2012 | 851 | 0.100 |
Why?
| | Laser Coagulation | 1 | 2014 | 77 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 2 | 2015 | 478 | 0.100 |
Why?
| | Nutrition Surveys | 2 | 2025 | 282 | 0.100 |
Why?
| | Weight-Bearing | 3 | 2026 | 181 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 103 | 0.100 |
Why?
| | Canada | 1 | 2014 | 428 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2016 | 514 | 0.100 |
Why?
| | Learning Curve | 1 | 2013 | 70 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 5 | 2001 | 361 | 0.100 |
Why?
| | Athletic Performance | 1 | 2014 | 76 | 0.100 |
Why?
| | Patient Selection | 3 | 2025 | 719 | 0.100 |
Why?
| | Gait | 1 | 2016 | 313 | 0.100 |
Why?
| | Health Status Disparities | 1 | 2016 | 321 | 0.100 |
Why?
| | Societies, Medical | 2 | 2014 | 887 | 0.090 |
Why?
| | Metals | 1 | 2014 | 142 | 0.090 |
Why?
| | Spirometry | 3 | 2001 | 231 | 0.090 |
Why?
| | Multivariate Analysis | 5 | 2017 | 1539 | 0.090 |
Why?
| | Arthrometry, Articular | 1 | 2012 | 9 | 0.090 |
Why?
| | Incidental Findings | 1 | 2013 | 80 | 0.090 |
Why?
| | Popliteal Vein | 1 | 2012 | 4 | 0.090 |
Why?
| | Pneumonia | 1 | 2018 | 631 | 0.090 |
Why?
| | Watchful Waiting | 1 | 2012 | 89 | 0.090 |
Why?
| | Ultrasonography | 3 | 2022 | 770 | 0.090 |
Why?
| | Nutritional Status | 1 | 2015 | 354 | 0.090 |
Why?
| | Posterior Cruciate Ligament | 1 | 2012 | 14 | 0.090 |
Why?
| | Severity of Illness Index | 6 | 2016 | 2925 | 0.090 |
Why?
| | Locomotion | 1 | 2012 | 105 | 0.090 |
Why?
| | Periodicals as Topic | 1 | 2014 | 203 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1694 | 0.090 |
Why?
| | Circumcision, Male | 1 | 2011 | 16 | 0.090 |
Why?
| | Osseointegration | 1 | 2012 | 60 | 0.090 |
Why?
| | Popliteal Artery | 1 | 2012 | 62 | 0.090 |
Why?
| | Prednisone | 3 | 2007 | 221 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2012 | 175 | 0.090 |
Why?
| | Registries | 2 | 2018 | 2385 | 0.090 |
Why?
| | Smoking | 1 | 2018 | 1472 | 0.080 |
Why?
| | Educational Measurement | 1 | 2014 | 326 | 0.080 |
Why?
| | Policy Making | 1 | 2011 | 82 | 0.080 |
Why?
| | Proteinuria | 3 | 2007 | 102 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2015 | 491 | 0.080 |
Why?
| | Tooth | 2 | 1990 | 45 | 0.080 |
Why?
| | Disability Evaluation | 1 | 2012 | 310 | 0.080 |
Why?
| | Interleukin-7 | 1 | 2010 | 65 | 0.080 |
Why?
| | Ankle Joint | 2 | 2023 | 122 | 0.080 |
Why?
| | Reference Standards | 1 | 2010 | 177 | 0.080 |
Why?
| | Preventive Health Services | 1 | 2011 | 152 | 0.080 |
Why?
| | Lead | 1 | 1990 | 70 | 0.080 |
Why?
| | Bicuspid | 2 | 1988 | 14 | 0.070 |
Why?
| | Upper Extremity | 1 | 2010 | 112 | 0.070 |
Why?
| | Cancer Vaccines | 1 | 2010 | 160 | 0.070 |
Why?
| | Molar | 2 | 1988 | 47 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2009 | 183 | 0.070 |
Why?
| | Transplant Recipients | 2 | 2022 | 180 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2014 | 414 | 0.070 |
Why?
| | Naturopathy | 1 | 2008 | 2 | 0.070 |
Why?
| | Pesticide Residues | 1 | 1988 | 4 | 0.070 |
Why?
| | Sepsis | 1 | 2015 | 640 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2012 | 339 | 0.070 |
Why?
| | Transillumination | 1 | 1988 | 3 | 0.070 |
Why?
| | Mexico | 2 | 2004 | 233 | 0.070 |
Why?
| | Urologic Diseases | 1 | 2008 | 40 | 0.070 |
Why?
| | Urography | 2 | 1998 | 19 | 0.070 |
Why?
| | Rheumatoid Factor | 3 | 2025 | 175 | 0.070 |
Why?
| | Insecticides | 1 | 1988 | 42 | 0.070 |
Why?
| | Heart Arrest | 2 | 2012 | 407 | 0.070 |
Why?
| | Glomerulonephritis, Membranous | 1 | 2007 | 3 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1289 | 0.070 |
Why?
| | Leptospira interrogans | 2 | 1985 | 4 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2019 | 1134 | 0.070 |
Why?
| | Systole | 2 | 2019 | 178 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2008 | 108 | 0.070 |
Why?
| | Ginkgo biloba | 1 | 2007 | 10 | 0.060 |
Why?
| | Dental Caries | 2 | 1988 | 173 | 0.060 |
Why?
| | Creatinine | 3 | 2008 | 506 | 0.060 |
Why?
| | Hospitalization | 3 | 2016 | 2433 | 0.060 |
Why?
| | Logistic Models | 3 | 2015 | 2117 | 0.060 |
Why?
| | HLA-DR Antigens | 2 | 1997 | 220 | 0.060 |
Why?
| | Lysholm Knee Score | 2 | 2016 | 8 | 0.060 |
Why?
| | Reagent Strips | 1 | 2006 | 8 | 0.060 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2001 | 636 | 0.060 |
Why?
| | Milk, Human | 1 | 1988 | 172 | 0.060 |
Why?
| | Depressive Disorder | 2 | 2006 | 387 | 0.060 |
Why?
| | Dental Enamel | 3 | 1990 | 67 | 0.060 |
Why?
| | Urine | 1 | 2006 | 62 | 0.060 |
Why?
| | Minimal Clinically Important Difference | 1 | 2025 | 30 | 0.060 |
Why?
| | Fatigue | 1 | 2008 | 366 | 0.060 |
Why?
| | Atmosphere Exposure Chambers | 2 | 1995 | 7 | 0.060 |
Why?
| | Nephrosis, Lipoid | 1 | 2005 | 11 | 0.060 |
Why?
| | Ligaments | 2 | 2020 | 75 | 0.060 |
Why?
| | Plant Extracts | 1 | 2007 | 187 | 0.060 |
Why?
| | Return to Work | 2 | 2015 | 21 | 0.050 |
Why?
| | Hyperparathyroidism | 1 | 2004 | 11 | 0.050 |
Why?
| | Shoulder Pain | 2 | 2018 | 36 | 0.050 |
Why?
| | Sleep | 2 | 2022 | 901 | 0.050 |
Why?
| | History, 21st Century | 1 | 2025 | 219 | 0.050 |
Why?
| | Lung | 2 | 1995 | 4109 | 0.050 |
Why?
| | Leukocytes | 1 | 2006 | 295 | 0.050 |
Why?
| | Vital Capacity | 2 | 1995 | 290 | 0.050 |
Why?
| | Regression Analysis | 4 | 2016 | 1003 | 0.050 |
Why?
| | Probability | 2 | 2006 | 310 | 0.050 |
Why?
| | Maternal Age | 1 | 2004 | 126 | 0.050 |
Why?
| | Weil Disease | 1 | 1983 | 1 | 0.050 |
Why?
| | Acidosis, Renal Tubular | 1 | 2003 | 4 | 0.050 |
Why?
| | Joint Capsule | 2 | 2016 | 10 | 0.050 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 37 | 0.050 |
Why?
| | Parathyroid Hormone | 1 | 2004 | 112 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2003 | 28 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2008 | 538 | 0.050 |
Why?
| | Forced Expiratory Volume | 2 | 1995 | 449 | 0.050 |
Why?
| | Radionuclide Angiography | 2 | 2001 | 3 | 0.050 |
Why?
| | Bicarbonates | 1 | 2003 | 45 | 0.050 |
Why?
| | Health Status | 2 | 2008 | 836 | 0.050 |
Why?
| | Social Justice | 1 | 2004 | 86 | 0.050 |
Why?
| | Felodipine | 1 | 2003 | 3 | 0.050 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2003 | 38 | 0.050 |
Why?
| | New England | 1 | 2003 | 37 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 854 | 0.050 |
Why?
| | Blood Chemical Analysis | 1 | 2003 | 109 | 0.050 |
Why?
| | Antibodies, Bacterial | 1 | 1983 | 148 | 0.050 |
Why?
| | Urinalysis | 2 | 2016 | 80 | 0.050 |
Why?
| | Evaluation Studies as Topic | 3 | 1998 | 166 | 0.050 |
Why?
| | Injections | 1 | 2023 | 196 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2023 | 316 | 0.050 |
Why?
| | Tissue Scaffolds | 1 | 2025 | 223 | 0.050 |
Why?
| | Receptors, Cholecystokinin | 1 | 2002 | 9 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2002 | 10 | 0.050 |
Why?
| | Dyslipidemias | 1 | 2024 | 181 | 0.050 |
Why?
| | Hormone Antagonists | 1 | 2002 | 34 | 0.050 |
Why?
| | Tomography, Emission-Computed | 1 | 2002 | 71 | 0.050 |
Why?
| | Nephritis, Hereditary | 1 | 2002 | 3 | 0.050 |
Why?
| | Enalapril | 1 | 2002 | 16 | 0.050 |
Why?
| | Environmental Exposure | 2 | 2001 | 588 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 350 | 0.040 |
Why?
| | Emergencies | 1 | 2023 | 175 | 0.040 |
Why?
| | Thiazoles | 1 | 2002 | 135 | 0.040 |
Why?
| | Nitrites | 1 | 2002 | 89 | 0.040 |
Why?
| | Infant | 8 | 2013 | 10034 | 0.040 |
Why?
| | Vaccines, Conjugate | 1 | 2002 | 60 | 0.040 |
Why?
| | Forecasting | 1 | 2023 | 391 | 0.040 |
Why?
| | Airway Resistance | 1 | 2001 | 38 | 0.040 |
Why?
| | Radiopharmaceuticals | 1 | 2002 | 194 | 0.040 |
Why?
| | Analysis of Variance | 4 | 2011 | 1306 | 0.040 |
Why?
| | Meningococcal Vaccines | 1 | 2002 | 58 | 0.040 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2002 | 156 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2016 | 333 | 0.040 |
Why?
| | Dentin | 2 | 1990 | 22 | 0.040 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1985 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2026 | 473 | 0.040 |
Why?
| | Albuminuria | 1 | 2002 | 190 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2003 | 202 | 0.040 |
Why?
| | Respiration | 1 | 2001 | 206 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2002 | 130 | 0.040 |
Why?
| | Bartter Syndrome | 1 | 2000 | 7 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 221 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2000 | 59 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2002 | 129 | 0.040 |
Why?
| | Heart Diseases | 1 | 2004 | 349 | 0.040 |
Why?
| | Renal Artery Obstruction | 1 | 2000 | 29 | 0.040 |
Why?
| | Poverty | 1 | 2004 | 529 | 0.040 |
Why?
| | Language Tests | 1 | 2000 | 23 | 0.040 |
Why?
| | Mental Status Schedule | 1 | 2000 | 35 | 0.040 |
Why?
| | Reference Values | 3 | 2000 | 797 | 0.040 |
Why?
| | Renal Artery | 1 | 2000 | 43 | 0.040 |
Why?
| | Consumer Product Safety | 1 | 2020 | 32 | 0.040 |
Why?
| | Cognition | 2 | 2007 | 1266 | 0.040 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 1999 | 27 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2001 | 2115 | 0.040 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2003 | 235 | 0.040 |
Why?
| | Bacterial Infections | 1 | 2002 | 246 | 0.040 |
Why?
| | Aggrecans | 1 | 2019 | 15 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 460 | 0.040 |
Why?
| | Vitamin E | 1 | 1999 | 121 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 479 | 0.040 |
Why?
| | HIV Infections | 2 | 2011 | 3154 | 0.040 |
Why?
| | Pediatrics | 2 | 2024 | 1114 | 0.040 |
Why?
| | Survival Rate | 2 | 2001 | 2089 | 0.040 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 17 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 201 | 0.040 |
Why?
| | Quality of Life | 2 | 2015 | 3185 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 338 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 143 | 0.040 |
Why?
| | Urinary Bladder | 2 | 1998 | 194 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 110 | 0.040 |
Why?
| | Serum | 1 | 2019 | 58 | 0.040 |
Why?
| | Research Subjects | 1 | 2018 | 41 | 0.040 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 124 | 0.040 |
Why?
| | Calcium | 1 | 2004 | 1183 | 0.030 |
Why?
| | Depression | 1 | 2008 | 1558 | 0.030 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2001 | 248 | 0.030 |
Why?
| | Thigh | 1 | 2018 | 47 | 0.030 |
Why?
| | Deltoid Muscle | 1 | 2017 | 6 | 0.030 |
Why?
| | Benzophenones | 1 | 2017 | 16 | 0.030 |
Why?
| | ROC Curve | 1 | 2000 | 614 | 0.030 |
Why?
| | Pectoralis Muscles | 1 | 2017 | 17 | 0.030 |
Why?
| | Cystoscopy | 1 | 1998 | 21 | 0.030 |
Why?
| | Sciatic Nerve | 1 | 2018 | 59 | 0.030 |
Why?
| | Radiographic Image Enhancement | 1 | 1998 | 57 | 0.030 |
Why?
| | Demography | 1 | 2018 | 288 | 0.030 |
Why?
| | Anatomic Landmarks | 1 | 2017 | 31 | 0.030 |
Why?
| | Dissection | 1 | 2018 | 56 | 0.030 |
Why?
| | HLA-DP Antigens | 1 | 1997 | 32 | 0.030 |
Why?
| | Torque | 1 | 2017 | 81 | 0.030 |
Why?
| | Brachial Plexus | 1 | 2017 | 35 | 0.030 |
Why?
| | Biomarkers | 3 | 2019 | 4271 | 0.030 |
Why?
| | Ketones | 1 | 2017 | 53 | 0.030 |
Why?
| | White Coat Hypertension | 1 | 2016 | 4 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2000 | 1325 | 0.030 |
Why?
| | Tarsal Bones | 1 | 2016 | 14 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2832 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 1997 | 173 | 0.030 |
Why?
| | User-Computer Interface | 1 | 1998 | 164 | 0.030 |
Why?
| | Glucose | 1 | 2002 | 1047 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 717 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 267 | 0.030 |
Why?
| | Respiratory Function Tests | 2 | 1996 | 547 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 289 | 0.030 |
Why?
| | Hominidae | 1 | 1997 | 87 | 0.030 |
Why?
| | Inspiratory Capacity | 1 | 1996 | 3 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1813 | 0.030 |
Why?
| | Frontal Lobe | 1 | 1997 | 160 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1241 | 0.030 |
Why?
| | Antioxidants | 1 | 1999 | 549 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 424 | 0.030 |
Why?
| | Lung Volume Measurements | 1 | 1995 | 46 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 144 | 0.030 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.030 |
Why?
| | Hemodynamics | 1 | 2000 | 1121 | 0.030 |
Why?
| | Endoscopy | 1 | 1998 | 316 | 0.030 |
Why?
| | Maximal Midexpiratory Flow Rate | 1 | 1995 | 5 | 0.030 |
Why?
| | Ossification, Heterotopic | 1 | 2015 | 18 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 1995 | 150 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2327 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1995 | 134 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2002 | 928 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 1995 | 83 | 0.030 |
Why?
| | Contraindications | 1 | 2015 | 91 | 0.030 |
Why?
| | Dental Pulp | 1 | 1974 | 4 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2004 | 6429 | 0.030 |
Why?
| | Decision Making | 2 | 2011 | 975 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2014 | 40 | 0.030 |
Why?
| | Essential Hypertension | 1 | 2014 | 2 | 0.030 |
Why?
| | Radiotherapy Dosage | 1 | 2015 | 289 | 0.030 |
Why?
| | Nutrition Assessment | 1 | 2015 | 92 | 0.030 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 1995 | 145 | 0.030 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 1994 | 19 | 0.030 |
Why?
| | Bronchoscopy | 1 | 1995 | 227 | 0.030 |
Why?
| | Periodontitis | 1 | 1974 | 54 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 121 | 0.030 |
Why?
| | Insurance, Health | 2 | 2014 | 302 | 0.030 |
Why?
| | Private Practice | 1 | 2014 | 19 | 0.030 |
Why?
| | Guided Tissue Regeneration | 1 | 2013 | 13 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2002 | 919 | 0.030 |
Why?
| | Bibliometrics | 1 | 2014 | 63 | 0.030 |
Why?
| | Urban Population | 2 | 1990 | 491 | 0.030 |
Why?
| | Educational Status | 2 | 2013 | 467 | 0.030 |
Why?
| | Biopsy | 3 | 2007 | 1075 | 0.030 |
Why?
| | Pregnancy | 2 | 2004 | 7190 | 0.030 |
Why?
| | Electric Stimulation Therapy | 1 | 1994 | 62 | 0.030 |
Why?
| | Polymers | 1 | 2017 | 499 | 0.030 |
Why?
| | Outpatients | 1 | 2017 | 442 | 0.020 |
Why?
| | Penile Diseases | 1 | 1993 | 5 | 0.020 |
Why?
| | Histoplasmosis | 1 | 1993 | 15 | 0.020 |
Why?
| | Caregivers | 1 | 2022 | 1049 | 0.020 |
Why?
| | Wounds, Penetrating | 1 | 1994 | 72 | 0.020 |
Why?
| | Acute Disease | 3 | 2015 | 1030 | 0.020 |
Why?
| | Exercise | 2 | 1995 | 2201 | 0.020 |
Why?
| | Academies and Institutes | 1 | 2013 | 60 | 0.020 |
Why?
| | Skull | 1 | 1994 | 158 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1382 | 0.020 |
Why?
| | Biological Evolution | 1 | 1997 | 488 | 0.020 |
Why?
| | Cervical Vertebrae | 1 | 2014 | 158 | 0.020 |
Why?
| | Inpatients | 1 | 2017 | 545 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 654 | 0.020 |
Why?
| | Pulmonary Edema | 2 | 2012 | 106 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 1995 | 509 | 0.020 |
Why?
| | France | 2 | 1990 | 40 | 0.020 |
Why?
| | Exercise Test | 1 | 1995 | 634 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2015 | 253 | 0.020 |
Why?
| | Sarcoma | 1 | 2015 | 205 | 0.020 |
Why?
| | North America | 1 | 2013 | 310 | 0.020 |
Why?
| | Sterilization | 1 | 2012 | 24 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 381 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1047 | 0.020 |
Why?
| | Personal Health Services | 1 | 1991 | 1 | 0.020 |
Why?
| | Papua New Guinea | 1 | 2011 | 10 | 0.020 |
Why?
| | Gamma Rays | 1 | 2012 | 56 | 0.020 |
Why?
| | Intestinal Obstruction | 2 | 1991 | 56 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1560 | 0.020 |
Why?
| | Health Planning Guidelines | 1 | 2011 | 24 | 0.020 |
Why?
| | Temporomandibular Joint | 1 | 1991 | 8 | 0.020 |
Why?
| | Denture, Complete | 1 | 1991 | 7 | 0.020 |
Why?
| | Mouth, Edentulous | 1 | 1991 | 10 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 886 | 0.020 |
Why?
| | Dentition | 1 | 1991 | 15 | 0.020 |
Why?
| | World Health Organization | 1 | 2011 | 105 | 0.020 |
Why?
| | Joint Capsule Release | 1 | 2011 | 2 | 0.020 |
Why?
| | Animals | 6 | 2019 | 38058 | 0.020 |
Why?
| | Prefrontal Cortex | 1 | 1994 | 328 | 0.020 |
Why?
| | Rhabdomyosarcoma | 1 | 1991 | 64 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2010 | 55 | 0.020 |
Why?
| | Mental Disorders | 1 | 2000 | 1168 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 648 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 184 | 0.020 |
Why?
| | Retinoids | 1 | 1990 | 33 | 0.020 |
Why?
| | Epidemiologic Methods | 2 | 1988 | 89 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 17 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2015 | 1030 | 0.020 |
Why?
| | Guanylate Cyclase | 1 | 1990 | 39 | 0.020 |
Why?
| | Intestine, Small | 1 | 1991 | 166 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 392 | 0.020 |
Why?
| | Bone Diseases | 1 | 1990 | 61 | 0.020 |
Why?
| | Substance Abuse, Intravenous | 1 | 1991 | 128 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 1953 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2583 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2011 | 280 | 0.020 |
Why?
| | HLA Antigens | 1 | 2010 | 225 | 0.020 |
Why?
| | New York | 1 | 2009 | 125 | 0.020 |
Why?
| | Equipment Failure | 1 | 2009 | 115 | 0.020 |
Why?
| | Health Services Research | 1 | 2011 | 396 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 53 | 0.020 |
Why?
| | Brain Injuries | 1 | 1994 | 507 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1047 | 0.020 |
Why?
| | Fourier Analysis | 2 | 2001 | 41 | 0.020 |
Why?
| | DDT | 1 | 1988 | 2 | 0.020 |
Why?
| | Polychlorinated Biphenyls | 1 | 1988 | 11 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 940 | 0.020 |
Why?
| | Tooth, Deciduous | 1 | 1988 | 19 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1989 | 142 | 0.020 |
Why?
| | Health Policy | 1 | 2011 | 400 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 485 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2008 | 122 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 379 | 0.020 |
Why?
| | Michigan | 2 | 1985 | 136 | 0.020 |
Why?
| | Capsules | 1 | 2007 | 43 | 0.020 |
Why?
| | HLA-DRB1 Chains | 2 | 1997 | 109 | 0.020 |
Why?
| | Lithotripsy | 1 | 2007 | 49 | 0.020 |
Why?
| | Placebos | 1 | 2007 | 192 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 74 | 0.020 |
Why?
| | Public Health | 1 | 2011 | 566 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2007 | 114 | 0.010 |
Why?
| | Angiography | 2 | 2000 | 208 | 0.010 |
Why?
| | Rodent Control | 1 | 1985 | 2 | 0.010 |
Why?
| | Cytokines | 1 | 2013 | 2061 | 0.010 |
Why?
| | Leptospirosis | 1 | 1985 | 8 | 0.010 |
Why?
| | Tooth Diseases | 1 | 1985 | 13 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1989 | 338 | 0.010 |
Why?
| | Tooth Extraction | 1 | 1985 | 28 | 0.010 |
Why?
| | Blood Gas Analysis | 2 | 2003 | 83 | 0.010 |
Why?
| | Amiodarone | 1 | 1985 | 31 | 0.010 |
Why?
| | Benzofurans | 1 | 1985 | 26 | 0.010 |
Why?
| | Attitude to Health | 1 | 2008 | 436 | 0.010 |
Why?
| | Rural Population | 1 | 1990 | 650 | 0.010 |
Why?
| | Memory | 1 | 2007 | 295 | 0.010 |
Why?
| | Alleles | 2 | 1997 | 879 | 0.010 |
Why?
| | Suburban Population | 1 | 1983 | 17 | 0.010 |
Why?
| | Inflammation | 1 | 1995 | 2878 | 0.010 |
Why?
| | Serum Albumin | 1 | 2004 | 147 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2027 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 108 | 0.010 |
Why?
| | Self Concept | 1 | 2006 | 253 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1985 | 165 | 0.010 |
Why?
| | Attention | 1 | 2007 | 457 | 0.010 |
Why?
| | Bronchopneumonia | 2 | 1973 | 6 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3540 | 0.010 |
Why?
| | Coronary Disease | 1 | 1985 | 383 | 0.010 |
Why?
| | Learning | 1 | 2007 | 452 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1982 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2003 | 183 | 0.010 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2002 | 13 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2010 | 956 | 0.010 |
Why?
| | Technetium | 1 | 2001 | 10 | 0.010 |
Why?
| | Likelihood Functions | 1 | 2001 | 143 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 535 | 0.010 |
Why?
| | Ifosfamide | 1 | 1999 | 38 | 0.010 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 1999 | 89 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 166 | 0.010 |
Why?
| | Carboplatin | 1 | 1999 | 160 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2001 | 230 | 0.010 |
Why?
| | Collagen | 2 | 1991 | 456 | 0.010 |
Why?
| | Combined Modality Therapy | 2 | 1994 | 1266 | 0.010 |
Why?
| | Cause of Death | 1 | 2000 | 471 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 769 | 0.010 |
Why?
| | Stroke Volume | 1 | 2001 | 651 | 0.010 |
Why?
| | HLA-DQ beta-Chains | 1 | 1997 | 57 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 1997 | 121 | 0.010 |
Why?
| | Animals, Zoo | 1 | 1997 | 15 | 0.010 |
Why?
| | Hylobates | 1 | 1997 | 8 | 0.010 |
Why?
| | Prevalence | 1 | 2004 | 2834 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 1997 | 7 | 0.010 |
Why?
| | Gorilla gorilla | 1 | 1997 | 18 | 0.010 |
Why?
| | Ileum | 1 | 1998 | 111 | 0.010 |
Why?
| | HLA-DP beta-Chains | 1 | 1997 | 87 | 0.010 |
Why?
| | Linkage Disequilibrium | 1 | 1997 | 246 | 0.010 |
Why?
| | Pan troglodytes | 1 | 1997 | 63 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 1999 | 573 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 1997 | 304 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1997 | 191 | 0.010 |
Why?
| | Hypoxia | 3 | 1973 | 1199 | 0.010 |
Why?
| | Gene Frequency | 1 | 1997 | 481 | 0.010 |
Why?
| | Haplotypes | 1 | 1997 | 490 | 0.010 |
Why?
| | Species Specificity | 1 | 1997 | 574 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1997 | 348 | 0.010 |
Why?
| | Electric Impedance | 1 | 1996 | 111 | 0.010 |
Why?
| | Heart Conduction System | 2 | 1989 | 95 | 0.010 |
Why?
| | Stem Cells | 1 | 1999 | 626 | 0.010 |
Why?
| | Dental Pulp Test | 1 | 1974 | 1 | 0.010 |
Why?
| | Alveolar Process | 1 | 1974 | 6 | 0.010 |
Why?
| | Tooth Mobility | 1 | 1974 | 5 | 0.010 |
Why?
| | Erythrocytes | 1 | 2001 | 757 | 0.010 |
Why?
| | Cell Movement | 1 | 1999 | 965 | 0.010 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1996 | 151 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 612 | 0.010 |
Why?
| | Health Behavior | 1 | 2000 | 785 | 0.010 |
Why?
| | Explosions | 1 | 1994 | 15 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1997 | 824 | 0.010 |
Why?
| | Accidents, Occupational | 1 | 1994 | 18 | 0.010 |
Why?
| | History, 19th Century | 1 | 1994 | 61 | 0.010 |
Why?
| | Equipment Design | 1 | 1996 | 530 | 0.010 |
Why?
| | Penis | 1 | 1993 | 32 | 0.010 |
Why?
| | New York City | 1 | 1993 | 89 | 0.010 |
Why?
| | Temperature | 1 | 1996 | 679 | 0.010 |
Why?
| | Nerve Endings | 1 | 1972 | 4 | 0.010 |
Why?
| | Rib Fractures | 1 | 1972 | 33 | 0.010 |
Why?
| | Baltimore | 1 | 1991 | 71 | 0.010 |
Why?
| | Mandibular Condyle | 1 | 1991 | 5 | 0.010 |
Why?
| | Connective Tissue | 1 | 1991 | 39 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1972 | 415 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1991 | 139 | 0.010 |
Why?
| | Temporal Bone | 1 | 1991 | 45 | 0.010 |
Why?
| | Atrophy | 1 | 1991 | 201 | 0.010 |
Why?
| | Income | 1 | 1991 | 202 | 0.000 |
Why?
| | Nitroprusside | 1 | 1990 | 72 | 0.000 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 85 | 0.000 |
Why?
| | Chromatography, Gel | 1 | 1990 | 131 | 0.000 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 331 | 0.000 |
Why?
| | Immunoblotting | 1 | 1990 | 300 | 0.000 |
Why?
| | Solubility | 1 | 1990 | 242 | 0.000 |
Why?
| | Disease Progression | 1 | 1997 | 2847 | 0.000 |
Why?
| | Syncope | 1 | 1989 | 55 | 0.000 |
Why?
| | Skin Diseases | 1 | 1990 | 149 | 0.000 |
Why?
| | Cardiac Pacing, Artificial | 1 | 1989 | 84 | 0.000 |
Why?
| | Enzyme Activation | 1 | 1990 | 766 | 0.000 |
Why?
| | Calcinosis | 1 | 1990 | 234 | 0.000 |
Why?
| | Osteoporosis | 1 | 1990 | 236 | 0.000 |
Why?
| | Cattle | 1 | 1990 | 1000 | 0.000 |
Why?
| | Absenteeism | 1 | 1986 | 53 | 0.000 |
Why?
| | Psychotropic Drugs | 1 | 1986 | 77 | 0.000 |
Why?
| | Oral Surgical Procedures, Preprosthetic | 1 | 1985 | 1 | 0.000 |
Why?
| | Tooth Eruption | 1 | 1985 | 10 | 0.000 |
Why?
| | Malocclusion | 1 | 1985 | 21 | 0.000 |
Why?
| | Tooth Injuries | 1 | 1985 | 9 | 0.000 |
Why?
| | Periodontal Diseases | 1 | 1985 | 62 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 1767 | 0.000 |
Why?
| | Heart Aneurysm | 1 | 1982 | 12 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1986 | 600 | 0.000 |
Why?
| | Cryosurgery | 1 | 1982 | 47 | 0.000 |
Why?
| | Hypotension | 2 | 1972 | 126 | 0.000 |
Why?
| | Carbon Dioxide | 2 | 1973 | 242 | 0.000 |
Why?
| | Streptococcal Infections | 2 | 1973 | 168 | 0.000 |
Why?
| | Suicide | 1 | 1986 | 720 | 0.000 |
Why?
| | Respiration, Artificial | 2 | 1972 | 708 | 0.000 |
Why?
| | Rats | 1 | 1985 | 5597 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1973 | 24 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1972 | 3 | 0.000 |
Why?
| | Anuria | 1 | 1972 | 3 | 0.000 |
Why?
| | Drowning | 1 | 1972 | 7 | 0.000 |
Why?
| | Embolism, Fat | 1 | 1972 | 11 | 0.000 |
Why?
| | Tracheotomy | 1 | 1972 | 23 | 0.000 |
Why?
| | Cyanosis | 1 | 1972 | 17 | 0.000 |
Why?
| | Positive-Pressure Respiration | 1 | 1973 | 112 | 0.000 |
Why?
| | Mitral Valve Stenosis | 1 | 1972 | 20 | 0.000 |
Why?
| | Pneumococcal Infections | 1 | 1973 | 103 | 0.000 |
Why?
| | Anti-Bacterial Agents | 2 | 1973 | 1907 | 0.000 |
Why?
| | Blood Proteins | 1 | 1973 | 249 | 0.000 |
Why?
| | Shock | 1 | 1972 | 108 | 0.000 |
Why?
| | Heparin | 1 | 1972 | 244 | 0.000 |
Why?
| | Resuscitation | 1 | 1972 | 302 | 0.000 |
Why?
| | Influenza, Human | 1 | 1973 | 616 | 0.000 |
Why?
| | Pneumonia, Viral | 1 | 1972 | 384 | 0.000 |
Why?
| | Hemorrhage | 1 | 1972 | 809 | 0.000 |
Why?
| | Oxygen | 1 | 1972 | 995 | 0.000 |
Why?
| | Alcoholism | 1 | 1972 | 817 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|